
Opinion|Videos|February 17, 2025
Advancing to Systemic Treatment in an 8-Year-Old Girl With Atopic Dermatitis
Author(s)Raj Chovatiya, MD, PhD, MSCI
The panelist discusses how an 8-year-old girl with moderate to severe atopic dermatitis requires a comprehensive treatment approach focusing on dupilumab as a potential systemic therapy. Treatment goals include reducing inflammation, improving quality of life, and providing age-appropriate, empathetic care while addressing patient and caregiver concerns about efficacy and safety.
Advertisement
Episodes in this series

Video content above is provided by the following:
- Please share your impressions of the case. What aspects of the case are most relevant for treatment consideration?
- What are your treatment goals for this patient?
- Describe your approach to pharmacologic treatment for this patient. Would her history and presentation make her a candidate for systemic therapy?
- How do you approach the conversation with pediatric patients and their caregivers when initiating a systemic, injectable treatment for atopic dermatitis?
- What should this patient expect in terms of efficacy and safety with dupilumab? How soon can she expect initial symptom relief?
- How would you address potential patient/caregiver concerns such as fear of injections or adverse effects and long-term safety with dupilumab?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5





















